The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin
Cancer is a set of complex diseases, being one of the leading causes of death worldwide. Despite a lot of research on the molecular pathways and effective treatments, there are still huge gaps. Indeed, the development of new anti-cancer drugs is a complex process. To face this problem, drug repurpos...
Main Authors: | Ana Salomé Correia, Lara Marques, Nuno Vale |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/45/4/218 |
Similar Items
-
Exploring the Role of Drug Repurposing in Bridging the Hypoxia–Depression Connection
by: Ana Salomé Correia, et al.
Published: (2023-09-01) -
Atorvastatin and Nitrofurantoin Repurposed in the Context of Breast Cancer and Neuroblastoma Cells
by: Catarina Moura, et al.
Published: (2023-03-01) -
Repurposing of atorvastatin emulsomes as a topical antifungal agent
by: Alaa S. Eita, et al.
Published: (2022-12-01) -
Atorvastatin-loaded emulsomes foam as a topical antifungal formulation
by: Alaa S. Eita, et al.
Published: (2022-12-01) -
Pharmacological or genetic inhibition of hypoxia signaling attenuates oncogenic RAS-induced cancer phenotypes
by: Jun-yi Zhu, et al.
Published: (2022-02-01)